The Migraine Prevention Stack: Magnesium, Riboflavin, CoQ10, and Feverfew

7 min read ·
Bottom Line

Magnesium, riboflavin, CoQ10, and feverfew are the rare supplement stack where each ingredient has its own randomized placebo-controlled trial for preventing migraine attacks, and all four carry an evidence-based rating from the American Academy of Neurology. The cleanest results are for riboflavin (400 mg/day made 59% of patients responders versus 15% on placebo) and magnesium (600 mg/day cut attacks by about 42% versus 16%), with CoQ10 and the standardized feverfew CO2 extract adding further trial support. These are daily prophylactics, not treatments for an attack in progress, and the benefit builds over roughly 8–12 weeks, so the protocol is judged on migraine days tracked over months. The key cautions are to avoid feverfew in pregnancy, titrate magnesium up slowly to avoid loose stools, and treat these as a complement to — rarely a replacement for — prescription preventives in frequent or disabling migraine.

Most supplement stacks rest on thin evidence. The migraine prevention stack is the rare exception: magnesium, riboflavin (vitamin B2), CoQ10, and feverfew each have randomized placebo-controlled trials for preventing migraine attacks, and all four carry an evidence-based (Level B or C) rating from the American Academy of Neurology and American Headache Society. These are prophylactics — taken daily to make attacks rarer and milder — not abortive treatments for an attack in progress. They work best for people with several migraine days per month who want to reduce frequency before, or alongside, prescription preventives. Benefits build over 8–12 weeks, so patience is part of the protocol.

Riboflavin (Vitamin B2), 400 mg Daily

Riboflavin is the standout for its simplicity and clean trial. In Schoenen's randomized controlled trial, riboflavin 400 mg/day beat placebo at reducing attack frequency and headache days over three months; 59% of riboflavin patients were "responders" (≥50% fewer attacks) versus 15% on placebo, with a number-needed-to-treat of about 2.3. The rationale is mitochondrial: riboflavin is a precursor to the flavin cofactors of the electron-transport chain, and impaired brain energy metabolism is implicated in migraine. It is cheap, very well tolerated (bright-yellow urine is the only common effect), and a sensible first choice. The catch is the dose — 400 mg is far above the multivitamin amount, so a dedicated product is needed.

Magnesium, 400–600 mg Daily

People with migraine tend to have lower brain and serum magnesium, and the ion is central to neuronal excitability and cortical spreading depression. In Peikert's randomized, double-blind trial, oral magnesium 600 mg/day cut attack frequency by 41.6% versus 15.8% on placebo over 12 weeks. Magnesium glycinate or citrate is better tolerated than oxide; the main side effect is loose stools, which is dose-limiting for some. Magnesium is also the component with the most appeal in menstrual migraine and migraine with aura. Start lower and titrate up to limit GI upset.

CoQ10 (Coenzyme Q10), 300 mg Daily

Like riboflavin, CoQ10 targets mitochondrial energy production. In Sandor's double-blind randomized trial, CoQ10 100 mg three times daily was superior to placebo for attack frequency, headache days, and days with nausea by the third month, with a 50%-responder rate of 47.6% versus 14.4% on placebo. CoQ10 is well tolerated; the practical limitations are cost and absorption (the ubiquinol form and taking it with a fatty meal help). It is a particularly common choice in adolescents and in people who also want the broader mitochondrial rationale.

Feverfew (Tanacetum parthenium), 6.25 mg CO2-Extract 3× Daily

Feverfew is the herbal member of the stack, traditionally used for headache and studied as the standardized CO2 extract MIG-99. In Diener's randomized, double-blind, multicenter trial, MIG-99 6.25 mg three times daily reduced migraine frequency significantly more than placebo, with an odds ratio of 3.4 in favor of feverfew for responders. Evidence across feverfew preparations is mixed — results depend heavily on the extract and parthenolide content — so the standardized CO2 extract is the version with the cleanest positive data. Feverfew should be avoided in pregnancy and in people allergic to the daisy (Asteraceae) family, and stopped gradually to avoid rebound headache.

How to Run the Stack

You do not need all four at once. A reasonable evidence-led approach is to start with riboflavin 400 mg/day (cheapest, cleanest trial) plus magnesium 400–600 mg/day, give it a full 8–12 weeks, and track migraine days in a diary — prophylaxis is judged on frequency over months, not on any single week. Add CoQ10 300 mg/day if response is partial, and consider standardized feverfew (CO2 extract) as a fourth layer. Notably, a randomized trial of a fixed magnesium-riboflavin-CoQ10 combination reduced migraine pain intensity and disease burden versus placebo, supporting the stack concept, though its effect on raw attack frequency only trended toward significance. Keep prescription preventives and acute treatments in the picture: these supplements lower the bar but rarely replace medication in frequent or disabling migraine. Avoid feverfew in pregnancy, titrate magnesium to bowel tolerance, and review the plan with a clinician if you are also on triptans or daily preventives.

Sources

  1. Schoenen J, Jacquy J, Lenaerts M. "Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial." Neurology, 1998;50(2):466-470. PMID: 9484373. DOI: 10.1212/wnl.50.2.466.
  2. Peikert A, Wilimzig C, Kohne-Volland R. "Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study." Cephalalgia, 1996;16(4):257-263. PMID: 8792038. DOI: 10.1046/j.1468-2982.1996.1604257.x.
  3. Sandor PS, Di Clemente L, Coppola G, et al. "Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial." Neurology, 2005;64(4):713-715. PMID: 15728298. DOI: 10.1212/01.WNL.0000151975.03598.ED.
  4. Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH. "Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention—a randomized, double-blind, multicentre, placebo-controlled study." Cephalalgia, 2005;25(11):1031-1041. PMID: 16232154. DOI: 10.1111/j.1468-2982.2005.00950.x.
  5. Gaul C, Diener HC, Danesch U; Migravent Study Group. "Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial." The Journal of Headache and Pain, 2015;16:516. PMID: 25916335. DOI: 10.1186/s10194-015-0516-6.